Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013350 |
---|---|
Receipt number | R000015578 |
Scientific Title | Phase 2 study of amrubicin plus bevacizumab in patients with previously treated advanced non-sq NSCLC |
Date of disclosure of the study information | 2014/03/06 |
Last modified on | 2014/03/06 11:02:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/03/06 11:02:48 |